Angel Yeast Subsidiary to Invest $370 Million in New Synthetic Biology Pilot Base

Stock News07-27

Angel Yeast Co.,Ltd. (SSE: 600298) announced that its wholly-owned subsidiary, Enzyme Preparation Company, plans to invest approximately 370 million yuan to build a new synthetic biology pilot verification base project.

This initiative aims to enhance the company's core competitiveness in the bio-manufacturing sector. The project is expected to commence construction in March 2027, with a construction period of 16 months.

The implementation of this project will help build an integrated pilot platform, accelerating the industrialization of products such as novel industrial enzyme preparations, new microbial proteins, and synthetic biology aqueous phase extraction. This aligns with the national development direction for the bio-manufacturing industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment